G. Gores
Hepatology · 2000–2020
A researcher in the Science corpus: 20 papers; trusts 7 researchers and is trusted by 5 researchers here, as inferred from the citation graph.
Subfields
- Hepatology — 182 citations into it; #116 of 151 by trust here, #53 by citations
- Molecular Biology — 137 citations into it; #13,598 of 17,773 by trust here, #5,764 by citations
- Oncology — 117 citations into it
- Surgery — 108 citations into it; #946 of 1,106 by trust here, #435 by citations
- Cancer Research — 75 citations into it; #1,545 of 1,780 by trust here, #952 by citations
- Pulmonary and Respiratory Medicine — 66 citations into it; #653 of 770 by trust here, #401 by citations
- Immunology — 28 citations into it
Whom G. Gores trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts G. Gores overall
Papers from G. Gores's perspective
Ordered by how strongly the researchers G. Gores trusts endorse each paper. Same corpus, a different order for every researcher.
- Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets.
- Inhibition of Mutated, Activated BRAF in Metastatic Melanoma (New England Journal of Medicine)
- Erlotinib in lung cancer - molecular and clinical predictors of outcome. (New England Journal of Medicine)
- Cholangiocarcinoma: Advances in Pathogenesis, Diagnosis, and Treatment (Hepatology)
- Burden of digestive diseases in the United States Part III: Liver, biliary tract, and pancreas. (Gastroenterology)
- Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function. (Molecules and Cells)
- Cholangiocarcinoma: Thirty-one-Year Experience With 564 Patients at a Single Institution (Annals of Surgery)
- Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States (Hepatology)
- Epithelial-mesenchymal transitions in development and disease. (Cell)
- Focal Gains of Vascular Endothelial Growth Factor A and Molecular Classification of Hepatocellular Carcinoma (Cancer Research)
Their papers
- mir-29 regulates Mcl-1 protein expression and apoptosis (2007) — 879 citations
- Free fatty acids promote hepatic lipotoxicity by stimulating TNF‐α expression via a lysosomal pathway (2004) — 740 citations
- Lysosomes in cell death (2004) — 732 citations
- Cathepsin B contributes to TNF-alpha-mediated hepatocyte apoptosis by promoting mitochondrial release of cytochrome c. (2000) — 749 citations
- Life and death by death receptors (2009) — 670 citations
- Cholangiocarcinoma 2020: the next horizon in mechanisms and management (2020) — 2,046 citations
- A global view of hepatocellular carcinoma: trends, risk, prevention and management (2019) — 3,633 citations
- Cholangiocarcinoma — evolving concepts and therapeutic strategies (2017) — 1,379 citations
- Hepatocellular carcinoma (2016) — 1,645 citations
- Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma. (2014) — 1,356 citations
- Hepatocellular carcinoma: clinical frontiers and perspectives (2014) — 1,329 citations
- Pathogenesis, Diagnosis, and Management of Cholangiocarcinoma (2013) — 1,224 citations
- Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report (2011) — 956 citations
- Clinical diagnosis and staging of cholangiocarcinoma (2011) — 699 citations
- Design and endpoints of clinical trials in hepatocellular carcinoma. (2008) — 1,196 citations
- Free Fatty Acids Induce JNK-dependent Hepatocyte Lipoapoptosis* (2006) — 710 citations
- Apoptosis and necrosis in the liver: A tale of two deaths? (2006) — 702 citations
- Liver Transplantation with Neoadjuvant Chemoradiation is More Effective than Resection for Hilar Cholangiocarcinoma (2005) — 638 citations
- Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis. (2003) — 1,046 citations
- Mechanisms of hepatotoxicity. (2002) — 1,347 citations